GLP-1
Semaglutide
The most studied GLP-1 receptor agonist, and the molecule behind the STEP trial results.
FSA & HSA eligibleWeight loss,Recovery,Cellular energy,Longevity,
Weight loss,Recovery,Cellular energy,Longevity,
decided by a doctor.
Enrollment opens once our licensed provider network is live. See current status
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. A prescription is issued only after review by a licensed independent provider who determines the treatment is appropriate. Individual results vary.
- A licensed U.S. physician reviews you and sets the protocol
- GLP-1, amylin and triple-agonist options — matched to your profile
- 100% online. No in-person visits, no insurance required
A plan that works for you.
All of you.
Onvytal is not a catalogue you pick from. You submit an intake, a physician reviews it, and the protocol comes back built around your profile — then gets adjusted as you go.
Provider-set protocol
A licensed physician reviews your intake and decides what, if anything, is appropriate.
Dose adjustments
Your protocol is revisited at each check-in rather than fixed at the start.
No in-person visits
Intake, review and follow-up all happen asynchronously online.
No insurance required
Flat plan pricing. Generally FSA and HSA eligible with an itemized receipt.
Cancel or pause anytime
No cancellation fees and no minimum term.
Treatment options
What a provider may consider
Which of these is appropriate — if any — is a clinical decision, not a selection you make. Nothing here is a recommendation.
GLP-1 · GIP · glucagon
Retatrutide
A triple receptor agonist in late-stage trials, combining appetite signalling with energy expenditure.
Amylin
Cagrilintide
A long-acting amylin analogue that acts on satiety through a pathway separate from GLP-1.
Longevity
NAD+
A core metabolic coenzyme studied for cellular energy and age-related decline.
Recovery
BPC-157
A synthetic pentadecapeptide studied in tissue-repair and angiogenesis models.
Energy
MOTS-C
A mitochondrial-derived peptide linked to AMPK signalling and metabolic regulation.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. This page is not medical advice and contains no dosing guidance.
What the trial data shows
15%
average body-weight reduction among adults with obesity taking FDA-approved semaglutide over 68 weeks, alongside diet and exercise, in the STEP 1 trial.
A published trial average for an FDA-approved product — not a projection of any individual outcome, and not a claim about compounded medication. Individual results vary.
Check your BMI
A starting data point for your intake — nothing more.
—
BMI is a screening estimate, not a diagnosis, and it does not determine eligibility. Only a licensed provider can decide whether a treatment is appropriate for you.
How it works
From intake to your door
- 1
Intake · about 10 min
Complete your health profile
Medical history, current medications, measurements and photo ID, submitted securely.
- 2
Provider review · within 24h
A licensed physician reviews it
Asynchronously — no video call. If treatment is appropriate, they set the protocol and dose.
- 3
Pharmacy fulfillment
Your prescription ships to you
Dispensed by a state-licensed compounding pharmacy in temperature-controlled packaging where required.
Our care model
Clinical specialties behind every plan
Onvytal does not employ physicians. We are building a network of independently licensed U.S. providers who make their own clinical decisions.
Obesity Medicine
Metabolic and weight-management care
Endocrinology
GLP-1 and hormonal health
Internal Medicine
Comprehensive review and treatment planning
Family Medicine
Longevity and peptide protocols
Sports Medicine
Recovery and regenerative protocols
No physician-patient relationship exists until a licensed provider reviews and accepts your intake.
Where we are right now
Being honest about what's live
The program described on this page is not yet operating. Here is exactly what is in place and what is still being built.
HIPAA-compliant platform In place
Intake and records infrastructure is in place.
Clinical protocols In place
Treatment criteria and review standards are written.
Licensed provider network In progress
Contracting with a U.S. telehealth provider group.
Compounding pharmacy In progress
Finalizing agreements with LegitScript-certified partners.
Prescriptions & fulfillment In progress
Not yet available. No prescriptions are issued through this site today.
FAQ
Common questions
Is Onvytal's weight-loss program available right now?
Not yet. We are contracting with a licensed U.S. provider network and a compounding pharmacy partner. No prescriptions are issued through this site today, and no payment is taken for the program.
What medications would a provider prescribe?
Depending on clinical judgement, a provider may consider semaglutide, retatrutide or cagrilintide for weight management, and BPC-157, MOTS-C or NAD+ for recovery and energy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. A prescription is issued only where a licensed provider determines it is appropriate.
What states will you serve?
The provider network is being onboarded to serve all 50 states and DC. Available treatments and dosing may vary by state regulation.
Do you take insurance?
We don't bill insurance directly. Treatment and consultation fees are generally FSA/HSA eligible, and you receive an itemized receipt for reimbursement.
Will there be in-person visits?
No. Intake, provider review and follow-up check-ins are all handled asynchronously online.
Can I cancel or pause once it launches?
Yes — pause or cancel from your account at any time, with no cancellation fees and no minimum term.
Weight loss, decided by a doctor.
We would rather launch late than issue a prescription through a network we have not finished vetting.
Enrollment opens once our provider network is live.
Onvytal is a technology platform and does not practise medicine. Prescriptions, where issued, come from independently licensed providers exercising their own clinical judgement, and are dispensed by state-licensed pharmacies. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Nothing on this page is medical advice or a dosing recommendation.